OLIPOP PBC Closes $30M Series B

OLIPOP PBC has secured $30.0 million in its latest funding round, providing significant capital to advance its mission in the functional beverage market.

The company is dedicated to positively impacting consumer health at scale by offering a new kind of soda that combines classic flavors with a functional ingredient blend designed to support the microbiome and digestive health.

This investment marks a pivotal moment for the brand as it continues its expansion.

At its core, OLIPOP aims to redefine the soda category by providing a delicious, refreshing, and health-conscious alternative to traditional sugary drinks.

The brand emphasizes its commitment to sourcing quality ingredients and fostering a culture that views business as a force for good, demonstrating that a beverage company can prioritize both taste and wellness.

This approach has resonated with a growing consumer base, leading to its widespread availability in over 65,000 retailers nationwide and sustained momentum in the competitive beverage industry.

This substantial capital infusion is poised to accelerate OLIPOP's strategic initiatives across various fronts.

The company plans to deploy the funds to further expand its market presence, enhance its operational capabilities, and invest in ongoing product innovation to meet evolving consumer demands.

This investment underscores investor confidence in OLIPOP's proven business model and its significant potential to capture a larger share of the rapidly expanding health-conscious beverage market.

Looking ahead, OLIPOP is focused on continuing its robust growth trajectory and strengthening its position as a leader in the functional soda segment.

The company remains committed to its founding mission of offering a healthier soda option and proving that beverages can contribute positively to consumer well-being, aiming to write a new American soda story one OLIPOP at a time.